MTOR and malignant peripheral nerve sheath tumor: Currently, a clinical trial is being carried out to test the effectiveness of selumetinib (AZD6244) and the mTOR inhibitor sirolimus in patients with unresectable or metastatic MPNST(NCT03433183).